CENTURY(SZ:300078)2020-04-29 16:00Financial Performance - The company reported a cash dividend of RMB 0.18 per 10 shares, totaling approximately RMB 15.7 million based on 869,411,466 shares[5]. - The company's operating revenue for 2019 was ¥1,573,993,606.47, representing a 21.58% increase compared to ¥1,294,633,555.55 in 2018[16]. - The net profit attributable to shareholders for 2019 was ¥147,607,911.10, a 2.88% increase from ¥143,472,605.91 in 2018[16]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 8.24% to ¥119,728,829.88 in 2019 from ¥130,481,298.93 in 2018[16]. - The net cash flow from operating activities improved significantly to ¥4,016,052.21 in 2019, compared to a negative cash flow of ¥2,250,476.51 in 2018, marking a 278.45% increase[16]. - Total assets at the end of 2019 reached ¥4,224,616,751.91, a 23.38% increase from ¥3,424,095,703.68 at the end of 2018[16]. - The net assets attributable to shareholders increased by 31.93% to ¥2,891,926,589.19 at the end of 2019 from ¥2,191,940,887.06 at the end of 2018[16]. - The company reported a basic earnings per share of ¥0.18 for 2019, unchanged from 2018[16]. - The company achieved operating revenue of 1,573.99 million yuan, a year-on-year increase of 21.58%[51]. - The net profit attributable to shareholders was 147.61 million yuan, up 2.88% compared to the previous year[51]. Research and Development - The company’s R&D investment totaled 161.20 million yuan, representing 10.24% of its operating revenue, indicating a strong commitment to innovation in smart medical and commercial intelligence sectors[40]. - R&D expenses amounted to 138.08 million yuan, representing 8.77% of operating revenue, indicating a continuous enhancement of the company's core competitiveness[56]. - The company achieved 100% completion on several key R&D projects, including wearable health monitoring systems and AI applications in healthcare[90]. - The company is actively developing an AI-driven healthcare management ecosystem, integrating various healthcare services through a smart health cloud platform[53]. - The company continues to invest in the independent research and development of artificial intelligence technology, solidifying its leading position in the medical AI field[43]. - The company has initiated several innovative projects, including smart shoes for elderly gait monitoring and RFID anti-theft solutions, aimed at enhancing its competitive edge[90]. Market Expansion and Strategy - The company is focused on expanding its market presence and enhancing its product offerings through new technologies and innovations[10]. - The company is actively involved in the healthcare information and management systems sector, aligning with industry trends[10]. - The company aims to leverage five core technologies: IoT, AI, big data interaction, microservice framework, and blockchain to enhance its smart healthcare solutions[25]. - The company is expanding its market presence through the development of IoT solutions, including the "Smart Bed Health Monitoring System V1.0" and "Hospital Indoor Navigation System Software V1.0" to enhance hospital management[47]. - The company has established partnerships with various hospitals and healthcare institutions to implement its software solutions, indicating a strategic approach to market expansion[46]. - The company is focusing on expanding its market presence through new product development and technological advancements[90]. Technology and Innovation - The company emphasizes the importance of RFID technology in its operations, which is crucial for automatic identification and data capture[10]. - The company has developed an integrated platform technology for EAS and RFID, covering various industries including supply chain management and digital retail, enhancing operational management for clients[43]. - The AI cognitive engine ThinkGo is at the core of the company's efforts to improve clinical diagnosis and treatment levels through deep learning[43]. - The company collaborates with Baidu to promote the deep integration of AI technology with medical scenarios[43]. - The company has developed RFID smart fresh storage and logistics solutions to address pain points in fresh e-commerce, supporting the growth of offline stores with technologies like electronic price tags and smart payments[62]. Governance and Compliance - The company is committed to maintaining the accuracy and completeness of its financial reports, as stated by its management[4]. - The company’s board of directors has fully attended the meeting to review the annual report, ensuring governance and oversight[5]. - The independent directors fulfilled their responsibilities in the decision-making process regarding profit distribution[139]. - The company ensured that minority shareholders had sufficient opportunities to express their opinions and protect their legal rights[139]. - The company has not reported any significant changes in non-main business activities during the reporting period[96]. Risks and Challenges - The company has outlined potential risks and corresponding measures in the section discussing future development prospects[5]. - Risks include potential delays in technology development and leakage, which could adversely affect the company's competitive edge[133]. - The company is managing risks related to accounts receivable, which have increased alongside revenue growth, potentially impacting cash flow[135]. - There is a risk of goodwill impairment from acquisitions if the performance of acquired companies does not meet expectations[136]. - The company faces intensified competition in the smart healthcare sector, necessitating continuous technological advancements and market exploration[132]. Social Responsibility and Compliance - The company actively fulfills its social responsibilities while ensuring shareholder value creation[184]. - The company emphasizes employee rights and adheres to relevant labor laws, focusing on employee health, safety, and satisfaction through training programs[185]. - The company operates within environmental protection standards, with no exceedances reported for pollutants such as PH, COD, and total phosphorus[187]. - The company is committed to lawful operations and actively contributes to local economic development through job creation and tax payments[185]. Shareholder Information - The proposed cash dividend for 2019 is RMB 0.18 per share, totaling RMB 15,649,406.39, based on a total share capital of 869,411,466 shares[140]. - The cash dividend for 2019 represents 10.60% of the net profit attributable to shareholders of the listed company[142]. - The cash dividend policy was executed in compliance with the company's articles of association and shareholder resolutions[139]. - The company has maintained a consistent cash dividend of RMB 0.18 per share for the past three years[141]. - The total distributable profit for 2019 was RMB 137,964,083.98, which is the lower of the consolidated and parent company reports[140].